The compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.

AACR 2025
Abstracts Sponsored by Bayer
April 25-30, 2025

Agenda of oral and poster presentations at the 2025 American Association for Clinical Research (AACR) Annual Meeting

Please see below to download a PDF for each presentation and view a video (where applicable). Access for each publication will be available after the congress presentation.

Please select a compound to navigate to all related publications.

 

 

PIPELINE

BAY 3547926: Novel targeted radionuclide therapy for hepatocellular carcinoma
Date/Time:
Monday, April 28, 2025 | 10:20 AM – 10:35 AM
Session:
Session DDT03 - New Drugs on the Horizon: Part 3
Type:
Oral
Presenting Author:
Jenny Karlsson
Presentation Number #:
ND09
Download the presentation
Novel synthetic lethality-based cellular assays for cancer drug discovery
Date/Time:
Monday, April 28, 2025 | 2:00 PM – 5:00 PM
Session:
Session PO.CH01.04 - High-Throughput Screening Assays and Libraries
Type:
Poster
Presenting Author:
Tom Grammatopoulos
Poster Number #:
3157/10
Download the poster
Discovery and characterization of BAY 3498264: a small molecule inhibitor targeting the RAS-SOS1 interaction
Date/Time:
Tuesday, April 29, 2025 | 9:00 AM – 12:00 PM
Session:
Session PO.ET09.12 - RAS Inhibitors
Type:
Poster
Presenting Author:
Shinghu Cheung
Poster Number #:
4373/8
Download the poster
A translational pharmacokinetic-pharmacodynamic (PKPD) modeling framework of novel, highly selective, next-generation allosteric cyclin-dependent kinase 2 (CDK2) inhibitors
Date/Time:
Tuesday, April 29, 2025 | 9:00 AM – 12:00 PM
Session:
Session PO.ET07.01 - Pharmacokinetics and Pharmacodynamics of Cancer Therapeutics
Type:
Poster
Presenting Author:
Andrea Gruber
Poster Number #:
4348/13
Download the poster
Fibroblast growth factor receptor (FGFR) inhibition demonstrates anti-tumor activity in succinate dehydrogenase deficient gastrointestinal stromal tumor (SDHd GIST)
Date/Time:
Tuesday, April 29, 2025 | 9:00 AM – 12:00 PM
Session:
Session PO.CT02.02 - Phase II Clinical Trials 2
Type:
Poster
Presenting Author:
Priscilla Merriam
Poster Number #:
CT215/7
Download the poster
BAY 2927088: a novel treatment option for patients with NSCLC with HER2 mutations
Date/Time:
Tuesday, April 29, 2025 | 2:00 PM – 5:00 PM
Session:
Session PO.ET09.13 - Kinase and Phosphatase Inhibitors 3
Type:
Poster
Presenting Author:
Franziska Siegel
Poster Number #:
5610/20
Download the poster

 

The compendium provided by Bayer is a compilation of Bayer sponsored presentations. Copies of presentations obtained from this compendium are for personal use only and may not be reproduced or distributed without permission from The American Association for Cancer Research (AACR) and from the authors. The compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Reused with permission. © 2025 The American Association for Cancer Research (AACR). All rights reserved.
For any questions, please contact Medical Information at 1-888-84-BAYER (1-888-842-2937), or visit https://www.medicalinformation.bayer.com/
© 2025 Bayer. All rights reserved. Bayer and the Bayer Cross are registered trademarks of Bayer. 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981 USA. 4/25

MA-BY-US-0039-1

The compendium provided by Bayer is a compilation of Bayer sponsored presentations. Copies of presentations obtained from this compendium are for personal use only and may not be reproduced or distributed without permission from The American Association for Cancer Research (AACR) and from the authors. The compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
Reused with permission. © 2025 The American Association for Cancer Research (AACR). All rights reserved.
For any questions, please contact Medical Information at 1-888-84-BAYER (1-888-842-2937), or visit https://www.medicalinformation.bayer.com/
© 2025 Bayer. All rights reserved. Bayer and the Bayer Cross are registered trademarks of Bayer. 100 Bayer Boulevard, PO Box 915, Whippany, NJ 07981 USA. 4/25

MA-BY-US-0040-1

© 2023 Bayer. All rights reserved.
Bayer and the Bayer Cross are registered trademarks of Bayer.
MA-M_DAR-US-0203-1
3/23

© 2023 Bayer. All rights reserved.
Bayer and the Bayer Cross are registered trademarks of Bayer.
MA-M_DAR-US-0204-1
3/23